Washington D.C.’s medical cannabis market experienced a huge leap in sales growth in March 2025. The Alcoholic Beverage and Cannabis Administration monthly medical cannabis sales report for March 2025 was a sign of light for the D.C. cannabis market. 

Monthly medical dispensary sales in D.C. rose over $3.1 million for the first time since June 2023 which was the last month before Maryland’s market launched its adult-use program. The increase in profits is welcome news for a market beleaguered by slow enforcement against illegal shops and intense competition in Maryland’s adult use market. 

This coincides with a decent market expansion on the retail side. 24 medical dispensaries were open in March 2025, just seven more than in February. However, these stores served an exploding patient population. 

Patients served grew significantly by over 5,000 people in March. About double the number of patients served last March which means the market doubled and grew more in one month than in the entire previous year. 

The March numbers also do not factor in the deadline to close unlicensed shops on Mar. 31 which caused a rush of new dispensaries to open in April. With these transitioned medical dispensaries, there has been an emphasis on bringing new patients into the medical market. And now, instead of a few dozen stores recruiting old I-71 patrons to D.C.’s now medical market, there are almost 40 operational shops across D.C. bringing in new patients. D.C. recently announced the closure of the 50th unlicensed store (though some of these have reopened). 

Manufacturers also sold a record breaking $1.4 million in product in March. The most they have sold in a month since sales were tracked separately starting in October 2023.

• Temporary non-resident patients grew by 3,137. 
• There will be 2,094 possible patient expirations in April, May and June
• There were 13 additional stores open and operating in April. There are 23 stores listed on the ABCA website that do not seem open according to their websites or lack thereof. 
• Temporary self-certification patient sales grew by over $350,000 in March. 
• Cultivation sales fell from February to March by just over $75,000. 
• Q2 2025 was still over $1.5 million lower in sales from the same quarter in 2024. 
• There were 36 scheduled inspections and 10 unlicensed facilities closed.